75 related articles for article (PubMed ID: 24436249)
1. Structural basis for the inhibition of AKR1B10 by caffeic acid phenethyl ester (CAPE).
Zhang L; Zhang H; Zheng X; Zhao Y; Chen S; Chen Y; Zhang R; Li Q; Hu X
ChemMedChem; 2014 Apr; 9(4):706-9. PubMed ID: 24436249
[TBL] [Abstract][Full Text] [Related]
2. Caffeic acid phenethyl ester (CAPE) possesses pro-hypoxia and anti-stress activities: bioinformatics and experimental evidences.
Bhargava P; Kumari A; Putri JF; Ishida Y; Terao K; Kaul SC; Sundar D; Wadhwa R
Cell Stress Chaperones; 2018 Sep; 23(5):1055-1068. PubMed ID: 29869000
[TBL] [Abstract][Full Text] [Related]
3. Bioactivity and chemical synthesis of caffeic acid phenethyl ester and its derivatives.
Zhang P; Tang Y; Li NG; Zhu Y; Duan JA
Molecules; 2014 Oct; 19(10):16458-76. PubMed ID: 25314606
[TBL] [Abstract][Full Text] [Related]
4. Effect of Withaferin-A, Withanone, and Caffeic Acid Phenethyl Ester on DNA Methyltransferases: Potential in Epigenetic Cancer Therapy.
Kumar V; Dhanjal JK; Sari AN; Khurana M; Kaul SC; Wadhwa R; Sundar D
Curr Top Med Chem; 2024; 24(4):379-391. PubMed ID: 37496252
[TBL] [Abstract][Full Text] [Related]
5. Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer.
Wu J; Omene C; Karkoszka J; Bosland M; Eckard J; Klein CB; Frenkel K
Cancer Lett; 2011 Sep; 308(1):43-53. PubMed ID: 21570765
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Human Cathepsins B and L by Caffeic Acid and Its Derivatives.
Ulčakar L; Novinec M
Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33383850
[TBL] [Abstract][Full Text] [Related]
7. Caffeic Acid Phenethyl Ester-Incorporated Radio-Sensitive Nanoparticles of Phenylboronic Acid Pinacol Ester-Conjugated Hyaluronic Acid for Application in Radioprotection.
Choi SH; Lee DY; Kang S; Lee MK; Lee JH; Lee SH; Lee HL; Lee HY; Jeong YI
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198522
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of caffeic acid phenethyl ester in cancer therapy: An updated review.
Pandey P; Khan F; Upadhyay TK; Giri PP
Chem Biol Drug Des; 2023 Jul; 102(1):201-216. PubMed ID: 36929632
[TBL] [Abstract][Full Text] [Related]
9. Selective Inhibition of Human AKR1B10 by
Seliger JM; Cicek SS; Witt LT; Martin HJ; Maser E; Hintzpeter J
Molecules; 2018 Nov; 23(11):. PubMed ID: 30469331
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting wild-type and C299S mutant AKR1B10; a homologue of aldose reductase upregulated in cancers.
Verma M; Martin HJ; Haq W; O'Connor TR; Maser E; Balendiran GK
Eur J Pharmacol; 2008 Apr; 584(2-3):213-21. PubMed ID: 18325492
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective Potential of Caffeic Acid Phenethyl Ester (CAPE) in CNS Disorders: Mechanistic and Therapeutic Insights.
Kulkarni NP; Vaidya B; Narula AS; Sharma SS
Curr Neuropharmacol; 2021; 19(9):1401-1415. PubMed ID: 34102977
[TBL] [Abstract][Full Text] [Related]
12. Substrate Specificity, Inhibitor Selectivity and Structure-Function Relationships of Aldo-Keto Reductase 1B15: A Novel Human Retinaldehyde Reductase.
Giménez-Dejoz J; Kolář MH; Ruiz FX; Crespo I; Cousido-Siah A; Podjarny A; Barski OA; Fanfrlík J; Parés X; Farrés J; Porté S
PLoS One; 2015; 10(7):e0134506. PubMed ID: 26222439
[TBL] [Abstract][Full Text] [Related]
13. Caffeic acid phenethyl ester: Unveiling its potential as a potent apoptosis inducer for combating hypopharyngeal squamous cell carcinoma.
Kim HJ; Ahn MH; Shin JA; Choi SJ; Yu HJ; Cho SD
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38099422
[TBL] [Abstract][Full Text] [Related]
14. Encapsulation of caffeic acid phenethyl ester by self-assembled sorghum peptide nanoparticles: Fabrication, storage stability and interaction mechanisms.
Song H; Ren S; Wang X; Hu Y; Xu M; Zhang H; Cao H; Huang K; Wang C; Guan X
Food Chem; 2024 Sep; 453():139642. PubMed ID: 38788643
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antitumor activity, and mechanism of action of 6-acrylic phenethyl ester-2-pyranone derivatives.
Fang S; Chen L; Yu M; Cheng B; Lin Y; Morris-Natschke SL; Lee KH; Gu Q; Xu J
Org Biomol Chem; 2015 Apr; 13(16):4714-26. PubMed ID: 25800703
[TBL] [Abstract][Full Text] [Related]
16. Decoding selectivity: computational insights into AKR1B1 and AKR1B10 inhibition.
Liu M; Qin X; Li J; Jiang Y; Jiang J; Guo J; Xu H; Wang Y; Bi H; Wang Z
Phys Chem Chem Phys; 2024 Mar; 26(12):9295-9308. PubMed ID: 38469695
[TBL] [Abstract][Full Text] [Related]
17. Cancer biomarker AKR1B10 and carbonyl metabolism.
Balendiran GK; Martin HJ; El-Hawari Y; Maser E
Chem Biol Interact; 2009 Mar; 178(1-3):134-7. PubMed ID: 19028477
[TBL] [Abstract][Full Text] [Related]
18. Interaction of olive oil-based propolis and caffeic acid phenethyl ester with methylprednisolone used in the treatment of human acute myeloid leukemia.
Dogan H; Ozcimen AA; Silici S
Mol Biol Rep; 2024 Apr; 51(1):559. PubMed ID: 38643306
[TBL] [Abstract][Full Text] [Related]
19. Repurposing of Strychnine as the Potential Inhibitors of Aldo-keto Reductase Family 1 Members B1 and B10: Computational Modeling and Pharmacokinetic Analysis.
Sarfraz M; Aziz M; Afzal S; Channar PA; Alsfouk BA; Kandhro GA; Hassan S; Sultan A; Hamad A; Arafat M; Qaiser MN; Ahmed A; Siddique F; Ejaz SA
Protein J; 2024 Apr; 43(2):207-224. PubMed ID: 37940790
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10.
Gallego O; Ruiz FX; Ardèvol A; Domínguez M; Alvarez R; de Lera AR; Rovira C; Farrés J; Fita I; Parés X
Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20764-9. PubMed ID: 18087047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
